Meulenbelt J - Search Results

1

The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling.

Ploeger B, Mensinga T, Sips A, Seinen W, Meulenbelt J, DeJongh J. Ploeger B, et al. Among authors: meulenbelt j. Drug Metab Rev. 2001 May;33(2):125-47. doi: 10.1081/dmr-100104400. Drug Metab Rev. 2001. PMID: 11495500 Review.

2

A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid.

Ploeger B, Mensinga T, Sips A, Deerenberg C, Meulenbelt J, DeJongh J. Ploeger B, et al. Among authors: meulenbelt j. Toxicol Appl Pharmacol. 2001 Jan 1;170(1):46-55. doi: 10.1006/taap.2000.9078. Toxicol Appl Pharmacol. 2001. PMID: 11141355 Clinical Trial.

3

A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling.

Ploeger B, Mensinga T, Sips A, Meulenbelt J, DeJongh J. Ploeger B, et al. Among authors: meulenbelt j. Pharm Res. 2000 Dec;17(12):1516-25. doi: 10.1023/a:1007661209921. Pharm Res. 2000. PMID: 11303962 Clinical Trial.

4

Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling.

Ploeger BA, Meulenbelt J, DeJongh J. Ploeger BA, et al. Among authors: meulenbelt j. Toxicol Appl Pharmacol. 2000 Feb 1;162(3):177-88. doi: 10.1006/taap.1999.8843. Toxicol Appl Pharmacol. 2000. PMID: 10652246

5

Health implications of exposure to environmental nitrogenous compounds.

Mensinga TT, Speijers GJ, Meulenbelt J. Mensinga TT, et al. Among authors: meulenbelt j. Toxicol Rev. 2003;22(1):41-51. doi: 10.2165/00139709-200322010-00005. Toxicol Rev. 2003. PMID: 14579546 Review.

6

Potato glycoalkaloids and adverse effects in humans: an ascending dose study.

Mensinga TT, Sips AJ, Rompelberg CJ, van Twillert K, Meulenbelt J, van den Top HJ, van Egmond HP. Mensinga TT, et al. Among authors: meulenbelt j. Regul Toxicol Pharmacol. 2005 Feb;41(1):66-72. doi: 10.1016/j.yrtph.2004.09.004. Epub 2004 Dec 10. Regul Toxicol Pharmacol. 2005. PMID: 15649828 Clinical Trial.

7

Bioavailability of carbamazepine from four different products and the occurrence of side effects.

Olling M, Mensinga TT, Barends DM, Groen C, Lake OA, Meulenbelt J. Olling M, et al. Among authors: meulenbelt j. Biopharm Drug Dispos. 1999 Jan;20(1):19-28. doi: 10.1002/(sici)1099-081x(199901)20:1<19::aid-bdd152>3.0.co;2-q. Biopharm Drug Dispos. 1999. PMID: 10086834 Clinical Trial.

8

Bioavailability of sodium nitrite from an aqueous solution in healthy adults.

Hunault CC, van Velzen AG, Sips AJ, Schothorst RC, Meulenbelt J. Hunault CC, et al. Among authors: meulenbelt j. Toxicol Lett. 2009 Oct 8;190(1):48-53. doi: 10.1016/j.toxlet.2009.06.865. Epub 2009 Jul 1. Toxicol Lett. 2009. PMID: 19576277 Clinical Trial.

9

Healthy volunteer studies in toxicology.

Meulenbelt J, Mensinga TT, Kortboyer JM, Speijers GJ, de Vries I. Meulenbelt J, et al. Toxicol Lett. 1998 Dec 28;102-103:35-9. doi: 10.1016/s0378-4274(98)00276-8. Toxicol Lett. 1998. PMID: 10022229

10

Effects of sub-chronic nitrate exposure on the thyroidal function in humans.

Hunault CC, Lambers AC, Mensinga TT, van Isselt JW, Koppeschaar HP, Meulenbelt J. Hunault CC, et al. Among authors: meulenbelt j. Toxicol Lett. 2007 Dec 10;175(1-3):64-70. doi: 10.1016/j.toxlet.2007.09.010. Epub 2007 Oct 2. Toxicol Lett. 2007. PMID: 17980977 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page